Related Experiment Videos
In vitro and in vivo effects of clindamycin on polymorphonuclear leukocyte function
1Department of Infectious and Parasitic Diseases, Hospital Infantil de Mexico, Federico Gómez, D.F.
Abstract:
The effects of clindamycin on polymorphonuclear leukocytes (PMNLs) were evaluated in vitro and in vivo in an experimental model and in immunocompromised patients with and without infection. Chemotaxis, chemiluminescence, and bactericidal capacity were evaluated using PMNLs preincubated with clindamycin in different concentrations. In the three phases of the study, clindamycin at a concentration of 2 mg/L significantly increased PMNL function. In contrast, when higher concentrations were used, PMNL function was not modified and in some cases it was decreased. Our findings suggest that clindamycin, in concentrations of 2 mg/L, positively modifies PMNL function.
Insights
Clindamycin at 2 mg/L enhances polymorphonuclear leukocyte (PMNL) function, improving immune response. Higher concentrations did not show this positive effect on PMNLs.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Polymorphonuclear leukocytes (PMNLs) are crucial for innate immunity.
- The impact of antibiotics like clindamycin on immune cell function requires further elucidation.
Purpose of the Study:
- To investigate the in vitro and in vivo effects of clindamycin on PMNL function.
- To determine the optimal concentration of clindamycin for modulating PMNL activity.
Main Methods:
- Evaluation of PMNL chemotaxis, chemiluminescence, and bactericidal capacity.
- Incubation of PMNLs with varying concentrations of clindamycin.
- Inclusion of experimental models and immunocompromised patients.
Main Results:
- Clindamycin at 2 mg/L significantly enhanced PMNL function across study phases.
- Higher clindamycin concentrations showed no improvement and sometimes decreased PMNL function.
- Observed effects in both experimental settings and clinical patient populations.
Conclusions:
- Clindamycin, at a concentration of 2 mg/L, demonstrates a positive modulatory effect on PMNL function.
- Therapeutic strategies may leverage specific clindamycin concentrations to support immune responses.
- Further research into antibiotic-immune cell interactions is warranted.